Clinical Trials Logo
  1. Home
  2. Retinitis Pigmentosa
  3. NCT00804102

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Retinitis Pigmentosa Clinical Trial

Official title:
Transcorneal Electrical Stimulation Therapy for Retinal Disease - A Randomized, Single-blind Pilot Study

Clinical Trial Summary

Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

  • Atrophy
  • Dry Age Related Macular Degeneration
  • Glaucoma
  • Glaucoma, Open-Angle
  • Hereditary Autosomal Dominant Optic Atrophy
  • Hereditary Macular Degeneration
  • Ischemia
  • Ischemic Macula Edema
  • Macula Off
  • Macular Degeneration
  • Non-Arthritic-Anterior-Ischemic Optic-Neuropathy
  • Optic Atrophy
  • Optic Atrophy, Autosomal Dominant
  • Optic Nerve Diseases
  • Optic Neuropathy, Ischemic
  • Primary Open Angle Glaucoma
  • Retinal Artery Occlusion
  • Retinal Detachment
  • Retinal Diseases
  • Retinal Vein Occlusion
  • Retinitis
  • Retinitis Pigmentosa
  • Treated Retina Detachment
Clinical Trial Details
NCT number NCT00804102
Study type Interventional
Source Okuvision GmbH
Contact
Status Completed
Phase N/A
Start date January 2008
Completion date April 2011
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT01432847 - Cell Collection to Study Eye Diseases
Completed NCT04983914 - Retrospective NIS to Evaluate the Patient Benefit of TES
Recruiting NCT03845218 - Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures
Completed NCT00231010 - Molecular Genetics of Retinal Degenerations
Active, not recruiting NCT04611503 - PDE6A Gene Therapy for Retinitis Pigmentosa Phase 1/Phase 2
Completed NCT02909985 - Visual Activity Evoked by Infrared in Humans After Dark Adaptation N/A
Recruiting NCT01914913 - Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa Phase 1/Phase 2
Completed NCT01949623 - Biomarkers In Retinitis Pigmentosa (BIRP) N/A
Completed NCT01835002 - Transcorneal Electrical Stimulation - Multicenter Safety Study N/A
Completed NCT00407602 - Argus® II Retinal Stimulation System Feasibility Protocol N/A
Completed NCT00515814 - Retina Implant Pilot Trial to Evaluate Safety & Efficacy in Blind Patients Having Degenerated Photo-receptors N/A
Completed NCT00100230 - DHA and X-Linked Retinitis Pigmentosa Phase 2
Active, not recruiting NCT00378742 - Repository for Inherited Eye Diseases
Terminated NCT05085964 - An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa Phase 2
Recruiting NCT05805007 - Safety and Tolerability Study of Gene Editing Drug ZVS203e in Participants With Retinitis Pigmentosa Early Phase 1
Recruiting NCT06291935 - Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene Phase 1
Recruiting NCT05909488 - Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II Phase 2/Phase 3
Recruiting NCT03078309 - The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients Early Phase 1
Completed NCT04238858 - Effects of Subtenon-injected Autologous Platelet-rich Plasma on Visual Functions in Eyes With Retinitis Pigmentosa N/A
Active, not recruiting NCT01680510 - The Effect of Oral Administration of 9-cis β Carotene Rich Powder of the Alga Dunaliella Bardawil Phase 1/Phase 2